Your session is about to expire
← Back to Search
Behavioural Intervention
Online Intervention for Gender Dysphoria
N/A
Waitlist Available
Led By Stephanie Budge, PhD, LP
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Awards & highlights
Study Summary
This trial aims to improve TNB well-being with an online intervention to reduce gender dysphoria. 100 TNB participants will provide feedback for a follow-up randomized controlled trial.
Who is the study for?
This trial is for transgender, transsexual, nonbinary individuals or those with a transgender history who experience gender dysphoria. Participants need to have time to commit to a 2-3-hour online intervention and an additional 1-2 hours for follow-up surveys.Check my eligibility
What is being tested?
The Trans Care Web App is being tested as an online intervention designed to reduce symptoms of gender dysphoria in TNB individuals. It includes eight modules aimed at improving coping strategies and overall well-being.See study design
What are the potential side effects?
Since this is a psychological support tool rather than a medical treatment, traditional physical side effects are not expected. However, participants may experience emotional discomfort while engaging with the content.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of Intervention Measure (AIM) Score
Digital Working Alliance Inventory (D-WAI) Score
Feasibility of Intervention Measure (FIM) Score
+3 moreSecondary outcome measures
Alcohol Use Disorder Identification Test
Brief Cope Score
Depression, Anxiety, and Stress Scale (DASS-21) Score
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Trans and Nonbinary AdultsExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,183 Previous Clinical Trials
3,167,487 Total Patients Enrolled
1 Trials studying Gender Dysphoria
260 Patients Enrolled for Gender Dysphoria
Stephanie Budge, PhD, LPPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
260 Total Patients Enrolled
1 Trials studying Gender Dysphoria
260 Patients Enrolled for Gender Dysphoria
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I identify as transgender, transsexual, nonbinary, or have a transgender history.I can dedicate 5-7 hours for an online intervention and surveys.I am under 18 years old.I do not identify as transgender, transsexual, nonbinary, or have a transgender history.
Research Study Groups:
This trial has the following groups:- Group 1: Trans and Nonbinary Adults
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants currently being accepted into this experiment?
"According to clinicaltrials.gov, this trial is not currently accepting participants. Initially posted on April 1st 2024 and last updated May 22nd 2023, it has since been surpassed by 381 other studies that are actively enrolling patients right now."
Answered by AI
Share this study with friends
Copy Link
Messenger